Campaign for Access to Essential Medicines, by Medecins Sans Frontieres

Untangling the Web of Antiretroviral Price Reductions

  • Access to ARVs
  • Drug Profiles
  • Annexes
  • References
  • Abbreviations
  • Downloads
  • News

Drug Prices & Patent Status

Browse By:

  • Drug
  • Company
  • Therapeutic Class

By Drug

  • abacavir
  • nelfinavir
  • abacavir/lamivudine
  • nevirapine
  • atazanavir
  • raltegravir
  • darunavir
  • ritonavir
  • didanosine
  • saquinavir
  • efavirenz
  • stavudine
  • emtricitabine
  • tenofovir disoproxil fumarate
  • enfuvirtide
  • tenofovir disoproxil fumarate/emtricitabine
  • etravirine
  • tenofovir disoproxil fumarate/emtricitabine/efavirenz
  • fosamprenavir
  • tenofovir disoproxil fumarate/lamivudine
  • indinavir
  • tenofovir disoproxil fumarate/lamivudine/efavirenz
  • lamivudine
  • tipranavir
  • lamivudine/stavudine
  • zidovudine
  • lamivudine/stavudine + efavirenz
  • zidovudine/lamivudine
  • lamivudine/stavudine/nevirapine
  • zidovudine/lamivudine + efavirenz
  • lopinavir/ritonavir
  • zidovudine/lamivudine/abacavir
  • maraviroc
  • zidovudine/lamivudine/nevirapine

Home

  • Access to ARVs
  • Drug Profiles
  • Annexes
  • References
  • Abbreviations
  • Downloads
MSF Campaign for Access to Essential Medicines  |  Rue de Lausanne 78 – Mailbox 116 – CH-1211 Genève 21
Phone:  +41 22 849 84 05  |  Fax:  +41 22 849 84 04  |  Email: